Concepedia

Author

Nadežda Basara

University Hospital Leipzig

Also Known As

Basara, N., N Basara, N M Basara, N. Basara, NADEZDA BASARA, Nadezda Basara, Nadežda Basara, Nadežda M. Basara, Sigrid Machherndl-Spandl

126

Publications

3.8K

Citations

31

H-Index

55

Concepts

All Affiliations

University Hospital LeipzigJohannes Gutenberg University MainzSt. Franziskus HospitalForschungsinstitut für Mineralische und Metallische Werkstoffe Edelsteine/EdemetalleMedizinische Hochschule Hannover
NB

About

Nadežda Basara is an author at University Hospital Leipzig specializing in medicine, hematology, and transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

28

1.4K

2

Health Sciences

8

8

417

3

Blood Transplantation

6

6

248

4

Cell Biology

4

4

106

5

Allergy

1

1

225

Nadežda Basara

×

58

Publications

3.5K

Citations

31

H-Index

YearCitations

Reduced Intensity Conditioning Compared With Myeloablative Conditioning Using Unrelated Donor Transplants in Patients With Acute Myeloid Leukemia

Olle Ringdén, Myriam Labopin, Gerhard Ehninger,

Journal of Clinical Oncology

2009

268

High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses

Stephan Metzelder, Thomas Schroeder, Anemone Finck,

Leukemia

2012

225

Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)

Michael Stadler, Martin Bornhäuser, Gesine Bug,

Blood

2005

199

Peripheral Blood Stem Cell Transplantation From Unrelated Donors: A Comparison With Marrow Transplantation

Olle Ringdén, Mats Remberger, Volker Runde,

Blood

1999

183

High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation

Nicola Gökbuget, Nadežda Basara, H. Baurmann,

Blood

2011

172

Second Allograft for Hematologic Relapse of Acute Leukemia After First Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors: The Role of Donor Change

Maximilian Christopeit, Jürgen Finke, Ulrike Bacher,

Journal of Clinical Oncology

2013

169

Diagnosis and Treatment of Ocular Chronic Graft-Versus-Host Disease: Report From the German–Austrian–Swiss Consensus Conference on Clinical Practice in Chronic GVHD

Tina Dietrich-Ntoukas, Claus Cursiefen, Henrike Westekemper,

Cornea

2011

150

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial

Dietrich W. Beelen, Rudolf Trenschel, Matthias Stelljes,

The Lancet Haematology

2019

147

No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors

Mats Remberger, Olle Ringdén, Igor‐Wolfgang Blau,

Blood

2001

120

Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients

Nadežda Basara, WI Blau, Eric J. Romer,

Bone Marrow Transplantation

1998

109

Page 1